Taipei, Taiwan

Sheng-Chieh Lin


Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Sheng-Chieh Lin

Introduction

Sheng-Chieh Lin is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals and electronic devices. With a total of two patents to his name, Lin's work showcases his innovative spirit and dedication to advancing technology.

Latest Patents

One of Sheng-Chieh Lin's latest patents is titled "Ammonium salts of 3-(3,5-dibromo-4-hydroxybenzyliden)-5-indo-1,3-dihydroindol-2-one and uses thereof." This patent discloses a compound that serves as an ammonium salt of GW5074, which has potential applications in cancer treatment. The pharmaceutical kit described in this patent includes a c-Raf inhibitor and a formulation containing the compound, aimed at treating subjects with cancer based on specific cellular detections.

Another patent involves a "Device with printed circuit board (PCB)." This invention details devices that include a first cover with engaging portions and a PCB positioned at an angle with respect to the base portion of the cover. This design enhances the functionality and usability of electronic devices.

Career Highlights

Sheng-Chieh Lin has worked with several companies, including Metagone Biotech Inc. and Verifone GmbH. His experience in these organizations has contributed to his expertise in both biotechnology and electronic device development.

Collaborations

Some of his notable coworkers include Tai-Lung Cha and Tai-Wei Ly. Their collaboration has likely fostered an environment of innovation and creativity in their respective fields.

Conclusion

Sheng-Chieh Lin's contributions to innovation, particularly in pharmaceuticals and electronic devices, highlight his role as a significant inventor. His patents reflect a commitment to improving technology and addressing critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…